PureHealth has entered into a partnership with Dell Technologies to integrate generative artificial intelligence (AI) into healthcare services, encompassing early disease detection, medical data analysis, and personalized treatment plans.
This collaboration aims to further enhance the healthcare ecosystem in Abu Dhabi by leveraging the combined resources and technologies of both companies to improve health outcomes and enhance long-term readiness and adaptability.
Through Dell’s innovative solutions, PureHealth seeks to have a positive impact on community well-being by providing improved patient experiences through intelligent healthcare decision-making and advancing health research.
GenAI Revolutionizes Healthcare with Early Detection and Personalized Treatment
The use of GenAI in healthcare offers numerous advantages, from early disease detection through in-depth medical data analysis to tailored treatment plans based on individual patient profiles. GenAI can also enhance the accuracy of medical imaging, facilitate predictive analytics for disease outbreaks, and expedite drug discovery, contributing to a more efficient and patient-centric healthcare environment.
Junaid Khan, Chief Technology Officer at PureHealth, and Walid Yehia, UAE’s General Manager of Dell Technologies, formalized the partnership through a signed agreement. Michael Dell, Founder, Chairman, and CEO of Dell Technologies, and Farhan Malik, Founder, Managing Director, and CEO of PureHealth, were present to witness the signing of this collaborative venture between the two organizations.
Junaid Khan, Chief Technology Officer at PureHealth, said: “As we embark on this transformative journey with Dell, we are thrilled to pioneer a new era in healthcare. This collaboration signifies our unwavering commitment to advancing the future of healthcare by harnessing the rapidly increasing computing power and normalising GenAI-based outcomes. By integrating GenAI, we are poised to revolutionise the industry, improve health outcomes, and fortify our healthcare system’s readiness for the future. Our efforts align seamlessly with our vision of extending human health span. GenAI is a powerful tool and will be incorporated in our digital transformation where we aim to take healthcare to the cloud.”
Walid Yehia, General Manager, UAE at Dell Technologies, said: “GenAI continues to drive meaningful conversations and propel tangible progress across industries. We are using our position as the world’s broadest GenAI infrastructure portfolio provider to help PureHealth deliver critical services to citizens.”
PureHealth’s Strategic Collaborations and Leadership in the Evolving Global Healthcare Landscape
The collaboration serves to further affirm PureHealth’s status as a prominent global healthcare provider, building on its recent significant acquisitions of Ardent Health Services, the fourth-largest private healthcare group in the United States, and Circle Health Group, the largest private healthcare group in the United Kingdom. This expansion aligns with Abu Dhabi’s vision to strengthen its position as a leading global hub for healthcare and life sciences.
Statista reports an expected growth in the global AI healthcare market, projecting it to reach a market size of AED686.8 billion by 2030 from its 2021 valuation of AED40.4 billion. This anticipated growth will substantially change the operations of medical providers, hospitals, pharmaceutical, and biotechnology companies.
PureHealth is actively reshaping the future of healthcare by strategically merging technology and data, pioneering innovative GenAI-driven solutions. With an extensive network that includes hospitals, clinics, diagnostic centres, insurance solutions, pharmacies, health tech, and procurement services, PureHealth continues to lead the way in advancing longevity science and transforming healthcare systems.
